PERITONEAL NEOPLASMS
Clinical trials for PERITONEAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new PERITONEAL NEOPLASMS trials appear
Sign up with your email to follow new studies for PERITONEAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise in slowing ovarian cancer
Disease control CompletedThis study tested whether adding two drugs—pembrolizumab (an immunotherapy) and olaparib (a targeted therapy)—to standard chemotherapy could help women with advanced ovarian cancer live longer without their cancer growing. Over 1,300 women with a type of ovarian cancer that does …
Matched conditions: PERITONEAL NEOPLASMS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Protein 'Fingerprint' may predict ovarian cancer relapse
Knowledge-focused CompletedThis study aimed to create a blood test that could predict when ovarian, peritoneal, or fallopian tube cancer might come back after remission. Researchers looked at proteins in the blood to find a pattern, or 'fingerprint,' linked to relapse. 119 women with stage III or IV cancer…
Matched conditions: PERITONEAL NEOPLASMS
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC